Evo sEEG System
Electrode, Depth. 510(k) K211367, from Neuroone Medical Technologies Corp. (Eden Prairie, MN). Product code GZL, class 2.
As of Nov 19, 2026, K211367 is an FDA 510(k) held by Neuroone Medical Technologies Corp., substantially equivalent on Sep 1, 2021 after 120 days, with no recalls tied to it in FDA's recall database.
- Review time: 120 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Evo sEEG System is intended for temporary (less than 24 hours) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain.
- DIXI Medical Microdeep Depth ElectrodeK170959 · Dixi Medical · Nov 24, 2017
- Evo® sEEG SystemK222404 · Neuroone Medical Technologies Corp. · Oct 20, 2022
- Wovyn Depth ElectrodeK253970 · Sensomedical Labs, Ltd. · Apr 17, 2026
- Depth Electrode (RSDE-08); Depth Electrode (RSDE-10); Depth Electrode (RSDE-12); Depth Electrode (RSDE-14); Depth…K250363 · Beijing Sinovation Medical Technology Co., Ltd. · Nov 5, 2025
- Neuro Omega System; NeuroSmart SystemK250601 · Alpha Omega Engineering , Ltd. · Mar 30, 2025
- Spencer Probe Depth ElectrodesK223269 · Ad-Tech Medical Instrument Corporation · May 18, 2023
- Anchor Bolts as Accessories to Depth ElectrodesK223276 · Ad-Tech Medical Instrument Corporation · May 18, 2023
- SENSOSEEG Depth ElectrodesK213170 · Sensomedical Labs, Ltd. · Apr 18, 2023
- iCE-SG2 Subcutaneous Electrode KitK222706 · Ice Neurosystems, Inc. · Dec 6, 2022
- Evo® sEEG SystemK222404 · Neuroone Medical Technologies Corp. · Oct 20, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 4, 2021
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1330
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files